URL copied
Covishield, Covaxin get govt s nod
Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India s Covishield vaccine and Bharat Biotech s Covaxin for emergency use against coronavirus. The development, eleven months after the first case of deadly coronavirus was detected in India, has paved the way for their roll-out and administration to millions. The vaccine will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crores elderly, mostly above the age of 50 years with co-morbidities.
The expert panel has recommended granting permission for restricted emergency use of Covaxin in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.
URL copied Image Source : PTI
Would make every Indian proud: PM Modi on DCGI final approval to Covishield, Covaxin for emergency use
The Drug Controller General of India (DCGI) on Sunday approved the emergency use of both Oxford-AstraZeneca Covishield vaccine and Bharat Biotechâs Covaxin vaccine for immunisation against Covid-19 in India. Prime Minister Narendra Modi took to Twitter to appreciate India s vaccine against Coronavirus and said it would make every Indian proud. We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives, PM Modi Tweeted.